Adaptive Biotechnologies (ADPT) Net Shares Issued and Repurchased (2018 - 2026)

Adaptive Biotechnologies has disclosed Net Shares Issued and Repurchased across 9 years of filings, most recently posting $15192.0 for Q1 2026.

• In Q1 2026, Net Shares Issued and Repurchased fell 98.0% year-over-year to $15192.0; the TTM figure through Mar 2026 stood at $15192.0 (down 98.0% YoY), while the FY2025 annual figure was $759724.0, down 24.66% from the prior year.
• Net Shares Issued and Repurchased came in at $15192.0 for Q1 2026 at Adaptive Biotechnologies, down from $759724.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $4.4 million in Q4 2022 to a low of $15192.0 in Q1 2026.
• Average Net Shares Issued and Repurchased over 5 years is $1.7 million, with a median of $1.0 million recorded in 2024.
• Year-over-year, Net Shares Issued and Repurchased jumped 128.1% in 2022 and plunged 98.0% in 2026.
• Over 5 years, Net Shares Issued and Repurchased stood at $4.4 million in 2022, then slumped by 63.57% to $1.6 million in 2023, then sank by 37.45% to $1.0 million in 2024, then retreated by 24.66% to $759724.0 in 2025, then sank by 98.0% to $15192.0 in 2026.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $15192.0 in Q1 2026, $759724.0 in Q4 2025, and $759724.0 in Q1 2025.